5-Azacytidine treatment in a beta (0)-thalassaemic patient unable to be transfused due to multiple alloantibodies.
Dunbar
C
C
Clinical Haematology Branch, National Heart, Lung and Blood Institute, Bethesda, Maryland 20892.
Travis
W
W
Kan
Y W
YW
Nienhuis
A
A
D000328:Adult; D001374:Azacitidine / Q000627:therapeutic use*; D006801:Humans; D007518:Isoantibodies / Q000302:isolation & purification; D008297:Male; D013789:Thalassemia / Q000188:drug therapy* / Q000276:immunology
D007518:Isoantibodies; D001374:Azacitidine